Literature DB >> 28967867

The decrease in population bone lead levels in Canada between 1993 and 2010 as assessed by in vivo XRF.

F E McNeill1, M Fisher, D R Chettle, M Inskip, N Healey, R Bray, C E Webber, W I Manton, L Marro, T E Arbuckle.   

Abstract

Objective and Approach: A study, conducted in Toronto, Canada, between 2009 and 2011, measured the bone lead concentrations of volunteers aged 1-82 years using in vivo x-ray fluorescence (XRF) technology. MAIN
RESULTS: Bone lead levels were lower compared to Ontario in vivo XRF studies from the early 1990s. In adults, the slope of tibia lead content versus age was reduced by 36-56%, i.e. bone lead levels for a given age group were approximately half compared to the same age group 17 years prior. Further, bone lead levels of individuals fell over that time period. In 2010, an average person aged 57 years had a bone lead level approximately 1/3 less than their bone lead level age 40 years in 1993. Using this data, the half-lives of lead in the tibia were estimated as 7-26 years. Tibia lead levels were found to be low in children. The reduction in bone tibia content in children was not significant (p  =  0.07), but using data from additional north eastern US studies, there is evidence that childhood tibia stores are lower than in the 1990s. SIGNIFICANCE: In vivo XRF analysis shows that there has been a reduction in the level of lead in bone in Canada over the last two decades. Public health measures have been very successful in reducing ongoing exposure to lead and in reducing bone lead stores.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28967867     DOI: 10.1088/1361-6579/aa904f

Source DB:  PubMed          Journal:  Physiol Meas        ISSN: 0967-3334            Impact factor:   2.833


  4 in total

1.  Comparison of bone lead measured via portable x-ray fluorescence across and within bones.

Authors:  Aaron J Specht; Aisha S Dickerson; Marc G Weisskopf
Journal:  Environ Res       Date:  2019-02-21       Impact factor: 6.498

2.  Lead exposure and association with angiogenic factors and hypertensive disorders of pregnancy.

Authors:  Katherine M Johnson; Aaron J Specht; Jessica M Hart; Saira Salahuddin; Adrienne L Erlinger; Michele R Hacker; Alan D Woolf; Marissa Hauptman; S Ananth Karumanchi; Blair J Wylie; Karen O'Brien
Journal:  Pregnancy Hypertens       Date:  2020-07-31       Impact factor: 2.899

3.  A novel calibration for L-shell x-ray fluorescence measurements of bone lead concentration using the strontium Kβ/Kαratio.

Authors:  Mihai R Gherase; Blaz Serna; Sarah Kroeker
Journal:  Physiol Meas       Date:  2021-05-14       Impact factor: 2.833

4.  Lead exposure and serum metabolite profiles in pregnant women in Mexico City.

Authors:  Megan M Niedzwiecki; Shoshannah Eggers; Anu Joshi; Georgia Dolios; Alejandra Cantoral; Héctor Lamadrid-Figueroa; Chitra Amarasiriwardena; Martha M Téllez-Rojo; Robert O Wright; Lauren Petrick
Journal:  Environ Health       Date:  2021-12-10       Impact factor: 7.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.